In a clinical trial of fecal transplantation in ulcerative colitis, it was discovered that Odoribacter is a type of metastatic bacteria that shapes mucosal immunity by increasing IL-10 expression and the production of SCFAs, resulting in an increase in regulatory T cells. This evidence concerns the gene IL10 and ulcerative colitis.